Trypanosoma brucei brucei: Characterization of an ODC null bloodstream form mutant and the action of alpha-difluoromethylornithine

Experimental Parasitology

Volumn 88, Issue 3, 1998, Pages 255-257

  Li, F ^a   Hua, S B ^b   Wang, C C ^b   Gottesdiener, K M ^a  

^a New York Presbyterian Columbia University Medical Center   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EFLORNITHINE; ORNITHINE DECARBOXYLASE;

ANIMAL CELL; ANIMAL MODEL; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; IN VITRO STUDY; MARKER GENE; MOUSE; MUTANT; NONHUMAN; POLYAMINE SYNTHESIS; PRIORITY JOURNAL; SHORT SURVEY; TRYPANOSOMA BRUCEI; VIRULENCE;

ANIMALIA; PROTOZOA; TRYPANOSOMA; TRYPANOSOMA BRUCEI BRUCEI;

EID: 0032031241     PISSN: 00144894     EISSN: None     Source Type: Journal    
DOI: 10.1006/expr.1998.4237     Document Type: Article

References (4)

1. Kuzoe F. A. S. Perspectives in research on and control of African trypanosomiasis. Annals of Tropical Medicine and Parasitology. 85:1991;33-41.
2. Li F., Gottesdiener K. M. An efficient method for stable transfection ofTrypanosoma brucei brucei. Nucleic Acids Research. 24:1996;534-536.
3. Li F., Hua S.-b., Wang C. C., Gottesdiener K. M. ProcyclicTrypanosoma brucei. Molecular and Biochemical Parasitology. 78:1996;227-236.
4. Wang C. C. Molecular mechanisms and therapeutic approaches to the treatment of African Trypanosomiasis. Annual Review of Pharmacology and Toxicology. 35:1995;93-127.